Evidence 1
Activity
Activity
31.8 ± 1.4% Hemolysis
Toxicity
100 µg/mL
Hemolytic
Cytotoxic
31.8 ± 1.4% Hemolysis | 100 | µg/mL | target cell: Human erythrocytes
Target
Human erythrocytes
Source & Reference
NA
DBAASP
Strategic modification of low-activity natural antimicrobial peptides confers antibacterial potential in vitro and in vivo. | Eur J Med Chem | 2023